Results 101 to 110 of about 2,765,640 (158)
Some of the next articles are maybe not open access.
Thrombosis and Haemostasis, 1971
SummaryA monospecific antiserum against factor X was prepared in rabbits. The antiserum precipitated factor X in human plasma and serum and monkey serum. The antiserum was used to :1. demonstrate the presence of factor X precursor in blood from patients under anticoagulant therapy,2.
H, Prydz, A, Gladhaug
openaire +2 more sources
SummaryA monospecific antiserum against factor X was prepared in rabbits. The antiserum precipitated factor X in human plasma and serum and monkey serum. The antiserum was used to :1. demonstrate the presence of factor X precursor in blood from patients under anticoagulant therapy,2.
H, Prydz, A, Gladhaug
openaire +2 more sources
Abnormal Factor X (Factor X Friuli) Coagulation Disorder
Acta Haematologica, 1973A new case with the abnormal factor X (factor X Friuli) coagulation disorder is presented: a 32-year- old female who was born outside Friuli and who complained of a bleeding tendency since childhood.
A, Girolami +3 more
openaire +2 more sources
Acta Haematologica, 1974
In two patients with the abnormal factor X (factor X Friuli) coagulation disorder a multiple tooth extraction was carried out immediately after the transfusion. X of 4 U of factor X concentrate (Bebulin) equivalent to 2,000 ml of normal plasma. No bleeding was noted. The half-life of the exogeneous component was 30 and 28 h, respectively.
A, Girolami, G, Molaro, L, De Marco
openaire +2 more sources
In two patients with the abnormal factor X (factor X Friuli) coagulation disorder a multiple tooth extraction was carried out immediately after the transfusion. X of 4 U of factor X concentrate (Bebulin) equivalent to 2,000 ml of normal plasma. No bleeding was noted. The half-life of the exogeneous component was 30 and 28 h, respectively.
A, Girolami, G, Molaro, L, De Marco
openaire +2 more sources
One Missense Mutation in the Factor X Gene Causing Factor X Deficiency—Factor X Kanazawa
International Journal of Hematology, 2001We investigated the molecular basis of factor X deficiency in a Japanese patient whose factor X activity and antigen level were 45% and 50% of normal control values, respectively. All exons and intron/exon junctions of the factor X gene were studied using a strategy combining polymerase chain reaction (PCR) amplification and nonradioactive single ...
E, Morishita +8 more
openaire +2 more sources
Archiv der Mathematik, 1993
Let \(K\) be a field and \(R=K[X^ 2,X^ 3]\). In this paper, we study lengths of factorizations in \(R\). For any atomic domain \(D\), define \(\rho(D)=\sup\{m/n\mid x_ 1\cdots x_ m= y_ 1\cdots y_ n\), \(y_ j\in D\) irreducible\} and \(\Phi(n)= |\{m\mid x_ 1\cdots x_ m= y_ 1\cdots y_ n\), \(x_ i, y_ j\in D\) irreducible\}\(|\). We show that \(\rho(R)=(D(
Anderson, David F. +3 more
openaire +2 more sources
Let \(K\) be a field and \(R=K[X^ 2,X^ 3]\). In this paper, we study lengths of factorizations in \(R\). For any atomic domain \(D\), define \(\rho(D)=\sup\{m/n\mid x_ 1\cdots x_ m= y_ 1\cdots y_ n\), \(y_ j\in D\) irreducible\} and \(\Phi(n)= |\{m\mid x_ 1\cdots x_ m= y_ 1\cdots y_ n\), \(x_ i, y_ j\in D\) irreducible\}\(|\). We show that \(\rho(R)=(D(
Anderson, David F. +3 more
openaire +2 more sources
Thrombosis and Haemostasis, 1965
Summary1. Methods have been developed for the preparation of factor VII free of prothrombin and factor X, and of factor X with only a very low contamination with factor VII.2. Factors VII and X could be found with one stage methods in purified prothrombin prepared according to Seegers.3. Purified prothrombin was chromatographed on DE AE-cellulose.
K, LECHNER, E, DEUTSCH
openaire +2 more sources
Summary1. Methods have been developed for the preparation of factor VII free of prothrombin and factor X, and of factor X with only a very low contamination with factor VII.2. Factors VII and X could be found with one stage methods in purified prothrombin prepared according to Seegers.3. Purified prothrombin was chromatographed on DE AE-cellulose.
K, LECHNER, E, DEUTSCH
openaire +2 more sources
Neutralization of factor X activity by factor X-specific monoclonal antibodies
Blood Coagulation & Fibrinolysis, 1992Factor X, a vitamin K-dependent protein, is the plasma zymogen for the active serine protease factor Xa. Factor Xa is the proteolytic enzyme for prothrombinase, the multi-protein membrane complex that catalyses the cleavage of prothrombin to thrombin.
L A, Ouellette +2 more
openaire +2 more sources
Factor X Vorarlberg, A New Variant of Hereditary Factor X Deficiency
Thrombosis and Haemostasis, 1979The proposita, a 56 years old woman, has a mild bleeding tendency. Prothrombin time was 112 sec (control 17.0 sec), stypven time 13.7 sec (control 11.5 sec) and APTT 54 sec (control 40 sec). Factor I, II (funct.and imm.), V, VII, VIII, IX, XI, XII, AT III were normal. - Factor X activity was < 1% by extrinsic system assay (tissue thromboplastin), 12%
K. Lechner +3 more
openaire +1 more source
The Factor‐X Defect: Recognition of Abnormal Forms of Factor X
British Journal of Haematology, 1970Summary. Six patients with the ‘Factor‐X defect’ have been investigated. At least five different forms of the defect were recognized by the use of the following laboratory tests: the kaolin cephalin clotting time as a measure of intrinsic clotting, the factor‐X assay employing either brain extract or Russell's viper venom, and the neutralization of a ...
K W, Denson +3 more
openaire +2 more sources
Assessment of Factor VII and Factor X
Thrombosis and Haemostasis, 1966SummaryA method is described to separate factor VII from factor X in normal serum using electrophoresis in a polyvinyl chloride block. A potent source of factor X is obtained. This may be used in correction studies and for assessment of deficiencies of factor VII in patients.
S, Shaw +3 more
openaire +2 more sources